RxDoctor Payments Data

Thomas Bambrick

Internal Medicine · Harvey, LANPI 1316926249

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.7% of the total across 156 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 19.5% — the pattern of someone who eats at a lot of different presentations.

$2,055in general payments, 2019–2025

Across 156 payments — averaging $13.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$400
  • Lilly USA, LLC$261
  • Merck$250
  • Boehringer Ingelheim$239
  • AstraZeneca$199
  • Johnson & Johnson$134
  • plus $572 from 14 others

What the payments were for

  • Food & beverage$2,049100%
  • Education$60%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,055 in reported general payments places this provider in the 75th percentile of 1,528 internal medicine providers in Louisiana.

See all internal medicine providers in Louisiana →

Other internal medicine in Harvey

See the full list for Louisiana →

Where these figures come from

Is this you, or does something look wrong? →